文献速递颈动脉与弓上血管

经颈动脉血运重建术中支架后球囊扩张对院内卒中和死亡的影响

Poststent ballooning during transcarotid artery revascularization.
PubMed 文献 · J Vasc Surg · 2020-11-27

基于VQI数据库2016年9月至2019年5月5161例TCAR患者,比较仅预扩、仅后扩及两者均行三组。后扩使用率65.3%,与院内卒中/死亡无独立关联(后扩OR 0.88,95%CI 0.44-1.73),但后扩组院内TIA风险约增4倍(OR 4.24,95%CI 1.51-11.8)。

要点

  • TCAR中支架后球囊扩张使用率65.3%,不增加院内卒中/死亡风险。
  • 后扩与院内TIA风险约增4倍相关(OR 4.24-4.76),需进一步研究。
  • 后扩组术后低血压和手术时间更长,但30天结局无显著差异。

核心结论

  • TCAR中支架后球囊扩张未增加院内卒中/死亡风险,但TIA风险约增4倍。

研究设计与样本

  • VQI数据库2016年9月至2019年5月5161例TCAR患者,分仅预扩、仅后扩、预扩+后扩三组。
  • 排除未行任何球囊扩张的367例(6.7%),采用单因素和多因素logistic回归分析。

主要发现

  • 仅预扩占34.7%,仅后扩占25%,预扩+后扩占40.3%。
  • 多因素分析:后扩与院内卒中/死亡无关联(仅后扩OR 0.88,95%CI 0.44-1.73;预扩+后扩OR 0.98,95%CI 0.57-1.70)。

临床怎么用

  • TCAR术中可考虑支架后球囊扩张,但需警惕TIA和术后低血压风险。
  • 后扩患者应加强围术期血流动力学和神经功能监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poststent ballooning/angioplasty (post-SB) have been shown to increase the risk of stroke risk after transfemoral carotid artery stenting. With the advancement of transcarotid artery revascularization (TCAR) with dynamic cerebral blood flow reversal, we aimed to study the impact of post-SB during TCAR. METHODS: Patients undergoing TCAR in the Vascular Quality Initiative between September 2016 and May 2019 were included and were divided into three groups: those who received prestent deployment angioplasty only (pre-SB, reference group), those who received poststent deployment ballooning only (post-SB), and those who received both prestent and poststent deployment ballooning (prepost-SB). Patients who did not receive any angioplasty during their procedure (n = 367 [6.7%]) were excluded because these represent a different group of patients with less complex lesions than those requiring angioplasty. Primary outcome was in-hospital stroke or death. Analysis was performed using univariable and multivariable logistic regression models. RESULTS: Of 5161 patients undergoing TCAR, 34.7% had pre-SB only, 25% had post-SB only, and 40.3% had both (prepost-SB). No differences in the rates of in-hospital and 30-day stroke, death, and stroke/death were observed among the three groups; in-hospital stroke/death in the pre-SB group was 1.4% (n = 25), post-SB 1.2% (n = 16), and prepost-SB 1.4% (n = 29; P = .92). However, patients undergoing post-SB and prepost-SB had higher rates of in-hospital transient ischemic attacks (TIA) (post-SB, 0.9%; prepost-SB, 1% vs pre-SB, 0.2%, P < .01) and postprocedural hypotension (16.6% and 16.8% vs 13.1%, respectively; P < .001). Post-SB also had longer operative times, as well as flow reversal and fluoroscopy times. On multivariable analysis, no association was seen between post-SB and the primary outcome of in-hospital stroke/death (post-SB odds ratio [OR], 0.88; 95% confidence interval [CI], 0.44-1.73; prepost-SB OR, 0.98; 95% CI, 0.57-1.70). Similarly, no significant differences were noted in terms of postprocedural hemodynamic instability and 30-day outcomes. However, post-SB and prepost-SB were associated with four times the odds of in-hospital TIA compared with pre-SB alone (post-SB OR, 4.24 [95% CI, 1.51-11.8]; prepost-SB OR, 4.76 [95% CI, 1.53-14.79]; P = .01). Symptomatic patients had higher rates of in-hospital stroke/death compared with their asymptomatic counterparts; however, there was no significant interaction between symptomatic status and ballooning in predicting the primary outcome. CONCLUSIONS: Post-SB was used in 65.3% of TCAR patients. This maneuver seems to be safe without an increase in the odds of postoperative in-hospital stroke/death. However, the increased rates of TIA associated with post-SB requires further investigation.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dakour-Aridi H, Cui CL, Barleben A, et al. Poststent ballooning during transcarotid artery revascularization. J Vasc Surg. 2020. PMID: 33253868. doi:10.1016/j.jvs.2020.10.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。